Innovative MedTech Inc. (IMTH)
USD 0.58
(34.88%)
USD 0.58
(34.88%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -7.67 Million USD | -127.75% |
| 2023 | -3.36 Million USD | 81.15% |
| 2022 | -17.79 Million USD | -3073.29% |
| 2021 | -3.08 Million USD | -49.98% |
| 2020 | - USD | -79.28% |
| 2019 | -39.62 Thousand USD | 0.0% |
| 2014 | -209.13 Thousand USD | -18.18% |
| 2013 | -335.26 Thousand USD | 79.95% |
| 2012 | -1.37 Million USD | -57.59% |
| 2011 | -899.49 Thousand USD | 28.02% |
| 2010 | -1.24 Million USD | -92.43% |
| 2009 | -660.29 Thousand USD | 51.95% |
| 2008 | -1.34 Million USD | -28.72% |
| 2007 | -1.04 Million USD | -363.04% |
| 2006 | -624.7 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -6.61 Million USD | -671.2% |
| 2024 Q3 | -886.81 Thousand USD | -577.04% |
| 2024 Q2 | -148.95 Thousand USD | -41.04% |
| 2024 Q1 | -69.47 Thousand USD | 87.95% |
| 2023 Q2 | -917.29 Thousand USD | 3.45% |
| 2023 Q1 | -950.09 Thousand USD | 94.57% |
| 2023 FY | - USD | 81.15% |
| 2023 Q4 | -782.7 Thousand USD | -6.4% |
| 2023 Q3 | -735.61 Thousand USD | 19.81% |
| 2022 FY | - USD | -3073.29% |
| 2022 Q4 | -17.5 Million USD | -10858.17% |
| 2022 Q3 | -159.77 Thousand USD | -185.35% |
| 2022 Q2 | -55.99 Thousand USD | 80.32% |
| 2022 Q1 | -284.44 Thousand USD | -426.55% |
| 2021 Q1 | -33.27 Thousand USD | 0.0% |
| 2021 Q4 | -54.02 Thousand USD | 86.61% |
| 2021 Q2 | -67.19 Thousand USD | -101.97% |
| 2021 Q3 | -403.55 Thousand USD | -500.57% |
| 2021 FY | - USD | -49.98% |
| 2020 FY | - USD | -79.28% |
| 2019 FY | - USD | 0.0% |
| 2015 Q1 | -110.62 Thousand USD | -88.63% |
| 2014 Q1 | -58.78 Thousand USD | 0.0% |
| 2014 Q4 | -58.65 Thousand USD | -1.28% |
| 2014 Q3 | -57.9 Thousand USD | 46.77% |
| 2014 FY | - USD | -18.18% |
| 2014 Q2 | -108.78 Thousand USD | -85.06% |
| 2013 FY | - USD | 79.95% |
| 2013 Q4 | -58.78 Thousand USD | -0.86% |
| 2013 Q1 | -739.07 Thousand USD | -353.58% |
| 2013 Q2 | -108.43 Thousand USD | 85.33% |
| 2013 Q3 | -58.28 Thousand USD | 46.25% |
| 2012 Q2 | -282.81 Thousand USD | -191.01% |
| 2012 FY | - USD | -57.59% |
| 2012 Q4 | -162.94 Thousand USD | 29.98% |
| 2012 Q3 | -232.71 Thousand USD | 17.71% |
| 2012 Q1 | -97.18 Thousand USD | 40.74% |
| 2011 Q1 | -566.38 Thousand USD | -80.74% |
| 2011 FY | - USD | 28.02% |
| 2011 Q4 | -163.99 Thousand USD | 57.08% |
| 2011 Q3 | -382.08 Thousand USD | -49.12% |
| 2011 Q2 | -256.22 Thousand USD | 54.76% |
| 2010 FY | - USD | -92.43% |
| 2010 Q1 | -85.8 Thousand USD | 30.62% |
| 2010 Q2 | -142.01 Thousand USD | -65.5% |
| 2010 Q3 | -174.79 Thousand USD | -23.08% |
| 2010 Q4 | -313.36 Thousand USD | -79.28% |
| 2009 Q1 | -262.02 Thousand USD | 35.35% |
| 2009 Q4 | -123.67 Thousand USD | 59.53% |
| 2009 Q3 | -305.61 Thousand USD | -102.77% |
| 2009 Q2 | -150.71 Thousand USD | 42.48% |
| 2009 FY | - USD | 51.95% |
| 2008 Q2 | -462.73 Thousand USD | -30.98% |
| 2008 Q1 | -353.27 Thousand USD | -4.74% |
| 2008 Q3 | -221.41 Thousand USD | 52.15% |
| 2008 Q4 | -405.31 Thousand USD | -83.06% |
| 2008 FY | - USD | -28.72% |
| 2007 Q3 | -140.95 Thousand USD | 34.92% |
| 2007 Q4 | -337.28 Thousand USD | -139.28% |
| 2007 FY | - USD | -363.04% |
| 2007 Q1 | -90.09 Thousand USD | 3.26% |
| 2007 Q2 | -216.6 Thousand USD | -140.4% |
| 2006 Q3 | -344.39 Thousand USD | 35.09% |
| 2006 Q2 | -530.58 Thousand USD | 0.0% |
| 2006 Q4 | -93.13 Thousand USD | 72.96% |
| 2006 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | -696.077% |
| Ansell Limited | 209.86 Million USD | 103.657% |
| Ansell Limited | 206.3 Million USD | 103.72% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 117.913% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | -372.249% |
| Psykey, Inc. | -1.29 Million USD | -492.434% |
| ConvaTec Group Plc | 455.5 Million USD | 101.685% |
| ConvaTec Group Plc | 455.5 Million USD | 101.685% |
| Encision Inc. | -544.19 Thousand USD | -1310.123% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -5311.337% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -6880.639% |
| LifePoint, Inc. | -14.2 Million USD | 45.967% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | -24.031% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | -2261.174% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -3465.337% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | -1791.109% |
| SmileDirectClub, Inc. | -186.13 Million USD | 95.877% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 101.714% |
| SheerVision, Inc. | -110.53 Thousand USD | -6842.683% |
| United Health Products, Inc. | -2.5 Million USD | -206.681% |
| Vasamed, Inc. | -4.57 Million USD | -67.754% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | -239.439% |
| Yubo International Biotech Limited | -1.17 Million USD | -551.601% |